Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial

BACKGROUND: While prednisolone is commonly used to treat recent nerve function impairment (NFI) in leprosy patients, the optimal treatment duration has not yet been established. In this “Treatment of Early Neuropathy in Leprosy” (TENLEP) trial, we evaluated whether a 32-week prednisolone course is m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenaar, Inge, Post, Erik, Brandsma, Wim, Bowers, Bob, Alam, Khorshed, Shetty, Vanaja, Pai, Vivek, Husain, Sajid, Sigit Prakoeswa, Cita Rosita, Astari, Linda, Hagge, Deanna, Shah, Mahesh, Neupane, Kapil, Tamang, Krishna Bahadur, Nicholls, Peter, Richardus, Jan Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643133/
https://www.ncbi.nlm.nih.gov/pubmed/28976976
http://dx.doi.org/10.1371/journal.pntd.0005952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643133/
https://www.ncbi.nlm.nih.gov/pubmed/28976976
http://dx.doi.org/10.1371/journal.pntd.0005952

Ejemplares similares